Open-source artificial pancreas study for type 1 diabetes in China
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This study looks at how well an open-source artificial pancreas system (a do-it-yourself insulin pump and continuous glucose monitor that talk to each other) works for people with type 1 diabetes in China. You can join if you already use this system and are willing to share your data.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have type 1 diabetes.
- You have been using an open-source artificial pancreas system for at least 3 months.
- You or your parent/guardian can agree to join the study and share your data.
- You live in China.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is a multi-site project designed for people who have type 1 diabetes and can use a smartphone app (WeChat or a similar app). It aims to collect research information in a way that’s easier to follow day to day, which may help improve future care for type 1 diabetes.
This study tests whether an artificial intelligence (AI) system can help manage insulin pump therapy remotely for people with type 1 diabetes. The goal is to improve blood sugar control and make diabetes management easier.
This study tests a system that measures blood sugar and automatically adjusts insulin delivery. It is for adults with type 1 diabetes who use insulin injections or a pump.
This study tests a new automated insulin delivery system to help people with type 1 diabetes better manage their blood sugar. It aims to see if the system improves glucose control safely.
This study tests a program to help people with type 1 diabetes improve their blood sugar control using continuous glucose monitors, insulin pumps, and education sessions. It includes remote monitoring and camp activities for some participants.
This study tests a smart insulin pump and continuous glucose monitor system that adjusts insulin automatically and uses behavior support to improve blood sugar control. It's for people with type 1 diabetes who have used an approved automated insulin delivery system recently and are willing to use study devices.
Hear when a new Type 1 Diabetes Mellitus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.